Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TUJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,115
Award facts
- Contract value 100% obligated
- $23,114.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,114.98 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on January 16, 2026, with completion expected by January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains significant contract relationships with the Defense Logistics Agency and supplies an extensive portfolio of medications across multiple therapeutic domains, including specialty pharmaceuticals, brand-name and generic drugs, vaccines, and medical devices. This delivery order for NURTEC ODT—a migraine treatment medication—demonstrates the company's ongoing role in fulfilling neurological medication requirements for the Defense Health Agency and other federal healthcare systems under the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26F3TUJ?
SPE2DR26F3TUJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F3TUJ worth?
The government has obligated $23,115 on SPE2DR26F3TUJ.
Is contract SPE2DR26F3TUJ an order under another contract?
Yes. SPE2DR26F3TUJ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TUJ competed?
The extent of competition for SPE2DR26F3TUJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award